Matthew Finston

Value, contrarian, social theorist, perspective
Matthew Finston
Value, contrarian, social theorist, perspective
Contributor since: 2014
Company: PnD
8/21/15
Matthew Finston
Earlier this year, I did a 4-part series predicting the #China market correction. Read part 4: http://seekingalpha.com/a/1ryke $FXI $BABA
8/21/15
Matthew Finston
Earlier this year, I did a 4-part series predicting the #China market correction Part 3: http://seekingalpha.com/a/1rxhs $FXI $BABA
8/21/15
Matthew Finston
Earlier this year, I did a 4-part series predicting the #China market correction Part 2: http://seekingalpha.com/a/1ra2g $FXI $BABA
8/21/15
Matthew Finston
Earlier this year, I did a 4-part series predicting the #China market correction Part 1: http://seekingalpha.com/a/1qk36 $FXI $BABA
8/12/15
Matthew Finston
$HTGM chief business officer John Lubniewski discloses open market purchase of 5,000 shares http://bit.ly/1UDi525
8/7/15
Matthew Finston
$HTGM democratizing tumor profiling with miRNA analysis
6/12/15
Matthew Finston
$BLK takes 10.4% in $HTGM http://1.usa.gov/1Gydd9t previously: $mrk 11.6% $GSK 16.12% $NVO 19% http://1.usa.gov/1Gydd9v
6/12/15
Matthew Finston
$BLK takes 10% in $HTGM http://1.usa.gov/1Gydd9t previously: $mrk 12% $GSK 16% $NVO 19% http://1.usa.gov/1Gydd9v
5/11/15
Matthew Finston
Bid increasing in $HK
5/11/15
Matthew Finston
NEW BUY: Franklin Resources $ben takes a 13.5% stake in $hk. HK trading at $1.30 from a high of $7.70 a share
5/11/15
Matthew Finston
if $mslp can keep having quarters with positive cash flow, it may have a chance of survival. current cash $4.8 million
5/5/15
Matthew Finston
Hege funds Ken Fisher, KORNITZER Cap. Mgmt, UBS are a few a of the names buying $IBN. india new growth opp?
5/5/15
IBN is great name with good management & I am a buyer.
5/5/15
Matthew Finston
$Xgti has moved up 160% in 5 days. Public offering announced today will correct that run http://1.usa.gov/1JnHCWX buy on the bounce?
warrants are priced at .26 a share. you know how investors get.
and down she goes
4/30/15
Matthew Finston
ICYMI: Proof Bill lied to HC, misled investors, & gross neg. http://bit.ly/1GFi7zT + $FITX admits BOD = 4 5yr-olds playing w teacup
4/30/15
Anyone besides rise51, still a billieber?
CEN BIOTECH LONG 1,043 members; Members (2,053) CEN Biotech/Creative Edge Nutrition Inc. (FITX) board
3/9/15
Matthew Finston
Note for article: "Risk averse: avoiding risk. Risk adverse: compulsively risky, causing self-harm. Risk-averse for the "risk adverse"
3/8/15
Matthew Finston
$MQTRF when did this happen?
3/9/15
Weird. I got nothing but an Oct 2014 article from Yhoo Fin. So, why no info on our exchange?
3/2/15
Matthew Finston
$ATRA Breakthrough therapy designation for EBV-CTL was based on data from two separate clinical trials of EBV-CTL conducted by MSK.
3/2/15
Matthew Finston
huge news $ATRA http://bit.ly/1B10RCR FDA Grants. . . .
2/26/15
Matthew Finston
$SDRL misses on EPS by -0.36 but in line with revenues
2/17/15
Matthew Finston
Putnam Investment discloses 5.7% $ocn stake. 22% increase. 0.1% of 48.7B AUM. 153th of 2936 holdings http://1.usa.gov/1vTdgKj
2/11/15
Matthew Finston
$EARS Auris granted AM-101 patent in china. Auris is developing two tinnitus drugs. I'm long. http://bit.ly/1zvaoOk
2/9/15
Matthew Finston
$RIG 11.4% up on fund holding disclosure. details to follow.
2/9/15
Matthew Finston
$RIG up on Blackrock's SC 13G/A filing disclosing a 285% position increase. Details to follow in article submitted for publishing.
12/21/14
Matthew Finston
Creative Edge Makes Front Page Canadian National News $FITX http://seekingalpha.com/a/1ndwb
12/16/14
Matthew Finston
Which Canadian MMPR Is Superior? Tweed, Bedrocan, Or Mettrum? $BNRDF, $TWMJF http://seekingalpha.com/p/24973
12/16/14
Matthew Finston
Marijuana Stocks: Canadian Court Strikes Down Feds Appeal To Overturn Injunction http://seekingalpha.com/a/1n4jn
12/15/14
Matthew Finston
The New Baupost Biotech Picks http://seekingalpha.com/a/1n2ep
12/15/14
Matthew Finston
Oil Crisis Punditry: Swinging The Fear In The Other Direction http://seekingalpha.com/a/1n1rn
12/11/14
Matthew Finston
for info on iron deficiency $KERX http://bit.ly/1Dj5z2C
12/11/14
Matthew Finston
$KERX TSAT levels improve by 8 points in study http://1.usa.gov/1utp2UW
You are really following Klarman!
I like how some of his picks seem completely divorced from reality.
12/11/14
Matthew Finston
Wearable tech has yet to boom $INVN http://onforb.es/1utl7r8 buyout rumor http://seekingalpha.com/n/1alet
12/11/14
Matthew Finston
$KERX presentation is extremely bullish http://bit.ly/1utgPzX